As health care costs overall have continued to rise, medicines are driving a good share of that trend. We'll look at some of the factors at play, including advertising, patents, and government programs and regulations -- also, plans underway on Capitol Hill to address the issue.
GUESTS:
- Sarah Ferris, health reporter for The Hill.
- Dr. Tom Stossel, visiting scholar the the American Enterprise Institute, where he researches and writes about health care policy. He is also a senior physician in the Hematology Division at Brigham and Women's Hospital in Boston and a professor at Harvard Medical School. His book is called Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical Innovation.
- Bob Woodward, health economist at the University of New Hampshire's Paul College of Business and Economics.
